Monday November 23 2009 | Biotechnology feed | All feeds

RHEI Pharmaceuticals, Inc.

http://www.rheipharma.com

RHEI Pharmaceuticals, Inc., New Haven Connecticut, United States of America.

RHEI Pharmaceuticals is a U.S.-based specialty pharmaceutical company that acquires, licenses, develops and commercializes therapies. RHEI partners with pharmaceutical and biotech companies to
RHEI Pharmaceuticals, Inc. - Company Profile

RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China

Friday 5th of December 2008 12:00

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

RHEI Pharmaceuticals Announces the Initiation of the Final ... RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China. New Product will Fill Void in the Local ...
http://www.prnewswire.com/news-releases/rhei-pharmaceuticals...
PRN Newswire - LA Times New Product will Fill Void in the Local Treatment of Oral Candidiasis in Immunosuppressed Patients in China PLAINSBORO, N.J., Dec. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=LATASI.sto...

Browse other news from this organisation: RHEI Pharmaceuticals, Inc.

Related Web-Links

(If any, Generated Automatically)

BioSpace - RHEI Pharmaceuticals, Inc. News, Search Jobs, Events

Source PR Newswire

PR Newswire Logo
www.prnewswire.co.uk

Browse news from 2008

Download PDF PDF Version

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.